Favorable skeletal benefit/risk of long-term denosumab therapy: A virtual-twin analysis of fractures prevented relative to skeletal safety events observed
Serge Ferrari, E. Michael Lewiecki, Peter Butler, David L. Kendler, Nicola Napoli, Shuang Huang, Daria B. Crittenden, Nicola Pannacciulli, Ethel S. Siris, Neil Binkley
Topics & Concepts
DenosumabMedicineOsteonecrosis of the jawAdverse effectPlaceboInternal medicineOsteoporosisRelative riskSurgeryBisphosphonateConfidence intervalPathologyAlternative medicineBone health and treatmentsBone and Joint DiseasesBone Metabolism and Diseases